Healthcare & Life Sciences
Gate Bio
United Statesgatebio.com
Gate Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
activeseries-b
series-b
Stage
1
Investors
About Gate Bio
Based in the United States, Gate Bio is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Gate Bio develops small molecule drugs called Molecular Gates that selectively block and eliminate harmful extracellular proteins by preventing their secretion, aiming to treat diseases caused by those proteins.
Explore Gate Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.